郑州近视眼打激光要多少钱(郑州近视眼做手术好吗) (今日更新中)

From California to South Carolina, a former Marine is riding is motorcycle across the country to raise money for Save the Brave.Major Scott Huesing is riding to honor his friend Dave White, a former Navy Veteran, who recently passed away from alcohol poisoning.When asked to give the eulogy at his friends funeral, Huesing want to do something more along the way. He's riding 4,600 miles round trip to raise money for Save the Brave, a nonprofit that's combating suicide and Post traumatic stress disorder among veterans and first responders."This pandemic has created a lot of fear for people and it’s isolated people," Huesing said. For veterans and people dealing with post traumatic stress, isolation is probably the worse thing for them. I think it’s probably the jump off point to where they reach hopelessness."According to a United States Department of Veterans Affairs Report, suicides are on the rise. In 2017, more than 45,000 Americans died from suicide and 6,130 of them were U.S. Veterans."I think right now people want to feel united around something and to be able to hop on my Harley and drive 4,600 miles round trip, I think that gives people a reason to come out and support," Huesing said.One of his first stops was in Tucson, but he's been riding ever since. You can follow his journey on Instagram.To donates to Save the Brave, go here. KGUN's Veronika Vernachio originally reported this story. 1439

My dad has only ever liked one video game - Galaga. He and my mom used to go play it on date nights when they were newly-weds and broke. This year, me and my siblings all pitched in to get him a Galaga arcade machine for Christmas. I don't think I've ever seen him more excited to get a present! 311

AURORA, Colo. -- Just as hundreds of restaurants are being forced to close down indoor dining, yet again, In-N-Out Burger made its debut in Colorado on Friday.Hundreds waited in line for hours to get a burger from the California-based fast-food chain.“It’s just a journey today,” said Charly, who came to relieve her dad who waited for three hours, but then had to go to work without making it to the front of the line.“Three or four hours wasn’t unexpected,” said Bob Fischer. “So, it’s definitely worth the wait.”Whether it was worth the wait depends on who you asked.But is it worth it? “No,” said Charly. “I don’t even eat beef. I’m just here for (my sister) and my dad.”In-N-Out’s arrival in Colorado comes at the most ill-timed or opportune moment, depending on your perspective.“I ordered about five cheeseburgers and five animal fries,” said one In-N-Out fan who did not wish to be identified. “It’s all about the uniqueness of the secret menu,” Fischer said.“I grew up in California, so we were always eating it,” said Maddie Duncan.Just around the corner, at the mom-and-pop NGL Burgers, owner Jesus Pulido is preparing to close to indoor dining yet again.“Tomorrow it’s back to take-out only or I can put some tables outside,” Pulido said.After 16 years in business in Aurora, Pulido, who’s also from California, certainly has his fans, too.“The food speaks for itself,” said an NGL regular named Zeke.“I grew up in L.A. There’s char-broiled burger places everywhere,” said Juan Lopez. “And this is exactly the same way.”Lopez says Pulido’s prices are right on the money.“If you’re going to let me pick for lunch, I’m going to come here because this is a better deal,” Lopez said.The question is – what kind of dent will In-N-Out, coupled with another COVID-19 shutdown put in Pulido’s business.He, for one, believes he will survive.“In-N-Out, that’s going to hurt me a little bit, you know? But I have my own customers,” Pulido said. “They want to go over there, whatever.”“To me – it’s important to keep these guys going,” Lopez said. “They know me so when I come here, you get the feeling of family and community.”This article was written by Russell Haythorn for KMGH. 2202

The Wauwatosa Police Department announced that a 15-year-old boy has been arrested in connection to the mass shooting at Mayfair Mall.Eight people including one teen were shot by a suspect at Mayfair Mall Friday afternoon. All are expected to survive their injuries, according to police.Police speculate that the shooting was not a random act but came after an altercation.During the preliminary investigation, witness accounts identified the suspect as a white man in his 20s or 30s. That has now been changed.No photos or videos of the suspect have been released. Once informed that the person was underage, police decided not to release images of the suspect.Police did say multiple arrests have been made.The investigation is still ongoing.This is a developing story. This story was originally published by Patricia McKnight of TMJ4.com. 863

INDIANAPOLIS — The U.S. Food and Drug Administration on Monday granted emergency use authorization to Eli Lilly and Company's experimental COVID-19 antibody treatment bamlanivimab.According to a statement from the company, the drug is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test who are at high risk for progressing to severe COVID-19 and/or hospitalization. Lilly said in a statement the drug should be administered as soon as possible after a positive COVID-19 test and within 10 days of symptom onset. The authorization allows for the distribution and emergency use of bamlanivimab, which is administered via a single intravenous infusion."This emergency authorization allows us to make bamlanivimab available as a COVID-19 treatment for recently diagnosed, high-risk patients — adding a valuable tool for doctors fighting the now-increasing burden of this global pandemic," David A. Ricks, Lilly's chairman and CEO, said. "The rapid development and availability of bamlanivimab could not have been achieved without the relentless work of our Lilly team, collaboration across the industry and the urgent work being done by the government to ensure appropriate allocation to patients who need it the most."The emergency use authorization is based on data from BLAZE-1, a randomized, double-blind, placebo-controlled Phase 2 study in patients with recently diagnosed mild to moderate COVID-19 in the outpatient setting. Patients treated with the drug showed reduced viral load and rates of symptoms and hospitalization, Lilly said in the statement. Infusion reactions and other allergic hypersensitivity events have been reported, Lilly said. The emergency use authorization includes a warning for hypersensitivity including anaphylaxis and infusion-related reactions.Lilly said the drug is not authorized for use in patients who are hospitalized due to COVID-19 or who require oxygen therapy due to COVID-19 or who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity."The BLAZE-1 data show bamlanivimab, when given early in the disease course, may help patients clear the virus and reduce COVID-related hospitalizations, supporting our belief that neutralizing antibodies can be an important therapeutic option for patients fighting this virus," Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific officer and president of Lilly Research Laboratories, said. "We're proud of the speed with which we have been able to bring patients this therapy specifically designed to treat COVID-19. We thank those who have contributed to this medical advancement, particularly the clinical trial investigators and participants around the country." This article was written by Bob Blake for WRTV. 2906

来源：资阳报